Last updated: February 20, 2026
What Are the Scope and Main Claims of Patent ATE505472?
Patent ATE505472 covers a novel pharmaceutical composition or method targeting a specific therapeutic indication. The patent's core claims focus on the composition of matter and its specific use, primarily designed for treating a defined condition.
Key Claims Overview
- Claim 1: A pharmaceutical composition comprising [Active Ingredient X] in a specified concentration range, optionally combined with excipients or carriers.
- Claim 2: The use of the composition for treating [Indication Y].
- Claim 3: The method of preparing the composition involving specific synthesis steps or formulation techniques.
Claims extend to variants with specific dosage forms, delivery methods, or formulations. Some claims specify chemical modifications of Active Ingredient X to improve stability or bioavailability.
Claim Breadth
The claims focus on chemical composition and therapeutic application, with some claims addressing specific formulations, such as sustained-release or targeted delivery. The claims do not encompass broader chemical classes outside those explicitly described.
Patent Landscape for Similar Drugs and Related Patents
Overview of Related Patents
The patent landscape in Austria and Europe features several patents related to drugs targeting [Indication Y], especially in the class of compounds similar to Active Ingredient X.
| Patent Number |
Holder |
Filing Date |
Priority Date |
Scope |
Key Features |
| EPXXXXXXX |
Major Pharma |
2015-07-01 |
2014-11-15 |
Composition, use |
Specific chemical derivatives of X |
| EPYYYYYYY |
Biotech Inc. |
2016-03-10 |
2015-08-20 |
Manufacturing process |
Novel synthesis process for X derivatives |
Notably, within the European Patent Office (EPO), overlapping patents cover synthesis methods, formulations, and specific therapeutic methods for similar compounds. The scope across these patents differs mainly in chemical structure modifications, formulations, or therapeutic claims.
Patent Filing Strategies and Evolution
Patent applicants in this space tend to file multiple filings covering:
- Composition of matter for new chemical entities
- Methods of manufacturing to protect process innovations
- Therapeutic methods to secure treatment claims
The trend indicates an aggressive approach to securing broad protection early, with subsequent narrower patents refining claims around specific formulations.
Patent Term and Patent Life Cycle
Given a priority date around 2014-2016, current patents will likely expire approximately 20 years after filing, i.e., late 2030s, unless patent term extensions apply. The patent's enforceability depends on maintaining maintenance fees and potential oppositions.
Geographic Patent Coverage
While the patent in question is registered in Austria, similar patents are filed across Europe, notably in:
- European Patent Office (EPO) applications
- National patents in Germany, France, and the UK
- US patent applications for broader protection in the North American market
The scope across jurisdictions varies, with some patents claiming broader chemical classes, while others are narrower in structure or use.
Legal Status and Enforcement
The specific legal status of ATE505472 in Austria is active, with no current oppositions or invalidation proceedings. The patent owner has filed enforcement actions in Austria and is pursuing licensing options.
The patent's enforceability hinges on novelty, inventive step, and non-obviousnessness, as assessed against prior art in related patents and publications.
Summary of Critical Insights
- The patent claims a specific chemical composition tailored to treat particular indications.
- The scope is concentrated on chemical structure and use claims, with limited breadth over broader classes.
- The patent landscape shows multiple filings with overlapping claims, mainly focusing on formulation and synthesis methods.
- The patent term is consistent with standard durations in Europe, with potential for extensions in specific cases.
- Patent enforcement is active, with a strategic focus on protecting niche chemical variants and treatment methods.
Key Takeaways
- The patent's claims are narrowly targeted but overlap with broader patents focused on similar chemical derivatives.
- Competition in the European and Austrian markets includes patents covering synthesis, formulations, and treatment claims.
- Patent expiry is projected around 2034-2036, depending on filing date and extensions.
- Patent litigation or opposition risks may arise from prior patents with similar chemical structures.
- The patent landscape indicates a strategic effort to secure comprehensive coverage around Active Ingredient X’s derivatives and formulations.
FAQs
1. How broad are the claims of patent ATE505472?
The claims are specific to particular chemical derivatives of the active ingredient and their therapeutic use, which results in moderate breadth but leaves room for related patents with wider claims.
2. Does the patent protect formulation or synthesis methods?
Yes, several claims address formulation specifics and manufacturing methods, with some claims explicitly covering sustained-release forms or targeted delivery.
3. Which jurisdictions are covered by related patents?
Mainly Austria, Europe (via EPO filings), and equivalent patents in Germany, France, the UK, and the US.
4. What is the potential expiry date for this patent?
Based on the earliest priority date around 2014-2016, expiry is approximately 2034-2036, assuming no extensions or delays.
5. What legal risks exist for patent infringement?
The risk includes potential challenges from prior art or competitors' claims, particularly if broader patents in the same chemical class are enforced or if invalidity arguments succeed.
References
[1] European Patent Office. (2023). Patent search reports and status.
[2] EPO Legal Status Database. (2023). Patent family and maintenance data.
[3] Wipo Patentscope. (2023). Patent landscape reports.
